FTC Seeks Contempt Charge For Pharma Douche

CNBC reports:

The Federal Trade Commission on Friday asked that notorious “pharma bro” Martin Shkreli be held in contempt of court for forming a new drug company in violation of a judge’s ban on the convicted fraudster from working in the pharmaceuticals industry.

Shkreli, who was released from prison last year, in February was banned “for life from directly or indirectly participating in any manner in the pharmaceutical industry” as a result of the FTC’s antitrust lawsuit against him and a prior drug company that he founded.

In its court filing Friday, the FTC noted that Shkreli in July announced the formation of a new company, Druglike, “that appears to be involved in the drug industry.” Shkreli was sentenced to seven years in prison in 2018. He was released into a federal halfway house last May.

Read the full article.

Last year Shkreli was ordered to return $65 million to investors. He has not complied. In 2017, while awaiting sentencing, his bail was revoked after he tweeted an offer of a $5000 bounty for a strand of Hillary Clinton’s hair.